Description
This session explores the complex intersection of ADHD, stimulant prescribing, and substance use risk, with a focus on clinical decision-making in both general and high-risk populations. We will review current evidence on the association between ADHD and substance use disorders, dispelling common myths while highlighting areas of true concern. The talk will cover strategies for safely prescribing stimulants, including considerations around formulation, co-prescribing with medications like naltrexone, and monitoring for misuse. Special attention will be given to managing ADHD in patients with active or remitted substance use disorders, balancing effective symptom control with minimizing harm. The session will also address real-world challenges such as diversion, patient stigma, and treatment engagement, offering practical guidance for clinicians working in outpatient, integrated, and addiction treatment settings. Attendees will leave with a framework for navigating these cases with nuance, safety, and confidence—particularly when working with adolescents and young adults.
Learning Objectives
Core Functions
Client Education, Consulting with Other Professionals, Crisis Intervention, Referral
Topic Category
Co-Occuring